- Home
- PAYS vs TARA Comparison
PAYS vs TARA Comparison
Compare PAYS & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAYS | TARA |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.4M | 268.5M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PAYS | TARA |
|---|---|---|
| Price | $5.76 | $4.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $9.42 | ★ $21.67 |
| AVG Volume (30 Days) | ★ 1.0M | 794.6K |
| Earning Date | 03-24-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 85.71 | 38.25 |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $24,120,434.00 | $2,948,000.00 |
| Revenue This Year | $21.22 | N/A |
| Revenue Next Year | $14.67 | N/A |
| P/E Ratio | $43.23 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.80 | $2.77 |
| 52 Week High | $8.88 | $7.82 |
Technical Indicators
Market Signals| Indicator | PAYS | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 81.90 | 36.70 |
| Support Level | $5.09 | $2.96 |
| Resistance Level | $5.83 | $5.39 |
| Average True Range (ATR) | 0.34 | 0.28 |
| MACD | 0.29 | -0.03 |
| Stochastic Oscillator | 88.99 | 9.04 |
Price Performance
Historical ComparisonAbout PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).